SOW
AMRX icon

State of Wyoming’s Amneal Pharmaceuticals AMRX Stock Holding History

State of Wyoming’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$702K Buy
56,478
+12,888
+30% +$173K 0.08% 172
2025
Q4 		$549K Sell
43,590
-13,094
-23% -$150K 0.06% 317
2025
Q3 		$567K Buy
56,684
+5,225
+10% +$46.9K 0.06% 252
2025
Q2 		$416K Sell
51,459
-30,313
-37% -$229K 0.05% 398
2025
Q1 		$685K Buy
81,772
+43,320
+113% +$362K 0.09% 126
2024
Q4 		$305K Sell
38,452
-4,184
-10% -$35.1K 0.04% 545
2024
Q3 		$355K Sell
42,636
-10,116
-19% -$79.1K 0.05% 339
2024
Q2 		$335K Sell
52,752
-5,374
-9% -$34.1K 0.06% 262
2024
Q1 		$352K Sell
58,126
-22,611
-28% -$128K 0.06% 268
2023
Q4 		$490K Buy
80,737
+8,060
+11% +$35.9K 0.09% 120
2023
Q3 		$307K Sell
72,677
-20,093
-22% -$74.9K 0.07% 216
2023
Q2 		$288K Buy
92,770
+7,143
+8% +$15.2K 0.08% 204
2023
Q1 		$119K Buy
85,627
+9,369
+12% +$18.7K 0.04% 662
2022
Q4 		$152K Buy
76,258
+24,333
+47% +$54.5K 0.05% 519
2022
Q3 		$105K Buy
51,925
+23,807
+85% +$66.7K 0.05% 570
2022
Q2 		$89K Buy
28,118
+7,020
+33% +$25.4K 0.06% 567
2022
Q1 		$88K Buy
21,098
+1,142
+6% +$5.06K 0.04% 691
2021
Q4 		$96K Buy
+19,956
New +$99.5K 0.04% 657

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State of Wyoming's AMRX Position: Q1 2026 in Review

State of Wyoming increased its Amneal Pharmaceuticals (AMRX) stake by 30% in Q1 2026, buying an estimated $173K and bringing the position to 56,478 shares worth $702K. The position accounts for 0.08% of the portfolio, ranked #172.

State of Wyoming first reported a position in AMRX in Q4 2021 and has held it in 18 quarters since. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • State of Wyoming held 56,478 shares of Amneal Pharmaceuticals worth $702K as of Q1 2026.
  • State of Wyoming bought 12,888 Amneal Pharmaceuticals shares in Q1 2026, an estimated $173K.
  • Amneal Pharmaceuticals made up 0.08% of State of Wyoming's portfolio in Q1 2026, its #172 holding.
  • State of Wyoming first reported a position in Amneal Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.